Where does Samuel Bjork work?

Samuel Bjork is Partner at Digitalis Ventures and Board director at Judo Bio and Board director at Bonum Therapeutics.

What check size does Samuel Bjork write?

Samuel Bjork typically writes checks of $100K – $10M.

Samuel Bjork

Investor

Partner at Digitalis Ventures · Chief Financial Officer at Panakes Partners · Board director at Judo Bio · Board director at Bonum Therapeutics · Founder at Terray Therapeutics

Brooklyn, New York

Writes $100K – $10M checks · typically $1.5M

About

Samuel Bjork is a Marshall Scholar with Harvard, Cambridge and Oxford backgrounds who pairs therapeutics investing with e-commerce, reflecting an engineering-health focus at the life-sciences and digital health/pet services intersection.

Contact· self-published, not guessed

s•••@digitalisventures.comreveal

Invests in

AI & Machine LearningBiotechDeep TechDigital HealthHardwareHealthtechMedical Devices

Board director at Judo Bio

Intro paths

→

In turn, Samuel can intro founders to Judo Bio's investors below.

Judo Bio's investors · 5

Atlas VentureCambridge · $500K – $1M checks Digitalis VenturesNew York · $100K – $10M checks Droia VenturesLeuven · $540K checks The Column GroupSan Francisco · $30M checks YK BioventuresBurlingame

Co-founders at Judo Bio

Andrew FraleyCo-founder

Alfica Sehgal

Board director at Bonum Therapeutics

Intro paths

→

In turn, Samuel can intro founders to Bonum Therapeutics's investors below.

Bonum Therapeutics's investors · 6

3x5 PartnersPortland Codon CapitalSan Francisco Digitalis VenturesNew York · $100K – $10M checks RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2026 Roche Venture FundBasel · $648K – $3.2M checks Vivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Bonum Therapeutics

John MulliganExecutive Officer, Director, Promoter

Founder at Terray Therapeutics

Intro paths

→

In turn, Samuel can intro founders to Terray Therapeutics's investors below.

Terray Therapeutics's investors · 8

Deviation CapitalNew York Digitalis VenturesNew York · $100K – $10M checks KdT VenturesAustin · $500K – $3M checks Madrona Venture GroupSeattle · $2M – $10M checks Mana VenturesEstero NVenturesSanta Clara Summit Peak InvestmentsFort Worth XTX MarketsBristol

Co-founders at Terray Therapeutics

Eli BerlinFounder

Investments

Board seats

Bonum TherapeuticsElemental MachinesEpiBiologicsGood TherapeuticsJudo BioNuvig TherapeuticsPetMedixProtegoScoutBioSeQure DxSwitch TherapeuticsT-TherapeuticsTerray Therapeutics

Per the firm's website.

Colleagues at Digitalis Ventures

Amit Bansal

Partner at Digitalis Ventures

Ben Jacobs

Partner at Digitalis Ventures

Bo Stewart

Associate at Digitalis Ventures

Cindy Cole

Technical Partner at Digitalis Ventures

Dac Nguyen

Technical Partner at Digitalis Ventures

Drew Taylor

Partner at Digitalis Ventures

Dylan Henderson

Accounting Manager at Digitalis Ventures

Geoffrey Smith

Founder / Managing Partner at Digitalis Ventures

Frequently asked questions

Who is Samuel Bjork?: Samuel Bjork is a Marshall Scholar with Harvard, Cambridge and Oxford backgrounds who pairs therapeutics investing with e-commerce, reflecting an engineering-health focus at the life-sciences and digital health/pet services intersection.
Where does Samuel Bjork work?: Samuel Bjork is Partner at Digitalis Ventures and Board director at Judo Bio and Board director at Bonum Therapeutics.
What does Samuel Bjork invest in?: Samuel Bjork invests in AI & Machine Learning, Biotech, Deep Tech, Digital Health, Hardware, Healthtech, Medical Devices.
What check size does Samuel Bjork write?: Samuel Bjork typically writes checks of $100K – $10M.
What boards does Samuel Bjork sit on?: Samuel Bjork holds tracked board seats at Bonum Therapeutics, Elemental Machines, EpiBiologics, Good Therapeutics, Judo Bio, Nuvig Therapeutics, PetMedix, Protego, ScoutBio, SeQure Dx.